Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracavernosal PRP vs Tadalafil for Erectile Dysfunction
NCT05787769Unknown
- Sponsor
- Mansoura University
- Start
- Mar 2023
- Primary completion
- Jan 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous platelet-rich plasma in erectile dysfunction (ED) (2 arms), sponsored by Mansoura University. Primary endpoint: Efficacy of intracavernosal injections of platelet-rich plasma at 6 months. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05787769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05787769.